Rocket Lab's Record High Evaporates as Insider Transfers and Technical Failures Trigger Sector Sell-Off

Rocket Lab shares fall from peak amid insider transfers, Neutron tank burst, and sector contagion, despite record $2.2B backlog and 64% revenue growth.

Rocket Lab's stock touched a 52-week high of $151 on May 28, only to see that peak erased within days by a confluence of internal and external shocks. Insider gifts, a burst test tank on the Neutron rocket, and a rival's catastrophic engine explosion combined to knock the shares back sharply, leaving the company's record backlog and surging revenues struggling to regain investors' attention.

Insider activity raises eyebrows despite gift classification

CFO Adam Spice transferred 188,172 shares on May 29 and June 1, and director Edward H. Frank gifted 182,746 shares in the same period. Both transactions were declared as gifts at zero dollar value—legally distinct from open-market sales. Spice still holds 920,325 shares directly plus 250,000 through trusts, while Frank's direct holdings dropped to 53,613 shares. Earlier in late May, SVP Arjun Kampani had sold 23,804 shares at around $147 apiece under a 10b5-1 plan, adding to the sense of insider profit-taking after the rally.

Neutron set back by tank rupture

The company's growth ambitions suffered a direct hit when a main-stage tank burst during testing of the Neutron vehicle. The incident forced Rocket Lab to push the maiden flight to mid-2026, which is later than the original target of late 2025 or early 2026. Neutron is critical for breaking into the constellation-launch market, and the delay fuels doubts about the capital-intensive development timeline. The company had earlier acquired Motiv Space Systems, now rebranded as Rocket Lab Robotics, to support the programme.

Sector-wide contagion from Blue Origin blast

The broader space industry was rattled when Blue Origin's New Glenn rocket exploded during an engine test in Florida. The news triggered a wave of selling across the sector. Rocket Lab shares tumbled 12% on Monday, June 1, according to one report, while another put the decline at 14.7% to $122.39. The following day the stock crept up 0.76% to close at $123.32—still far from the recent high.

Defense milestones provide a counterweight

Amid the turmoil, Rocket Lab quietly notched a defence achievement. On June 1, it completed the System Requirements Review for the U.S. Space Development Agency's Tracking Layer Tranche 3, confirming the technical viability of its missile-warning satellite design. This follows a $90 million Space Force contract for the Heimdall programme, covering two geostationary satellites. The Space Systems segment has overtaken launch as the largest revenue contributor.

The company's order backlog stands at a record $2.2 billion, and first-quarter 2026 revenue surged 64% year-over-year to $200 million. Over the trailing twelve months, revenue reached $679.6 million, a 46% increase. Yet the stretched valuation—a price-to-earnings ratio of 137.9—leaves little room for disappointment.

Analyst targets lag the recent peak

Several banks have raised their price targets, but none match the $151 high. New Street Research initiated with Buy and a $150 target, while Deutsche Bank and Needham & Co. both lifted their targets to $120. Cantor Fitzgerald reiterated its Overweight rating. The consensus suggests the market briefly outpaced fundamentals in May.

The next catalyst: SpaceX IPO and Neutron race

The upcoming SpaceX initial public offering, scheduled for June 12, is expected to draw capital away from smaller space names. Some strategists warn of a "sell the news" effect that could further pressure Rocket Lab. The company's near-term fate hinges on how quickly it can recover from the Neutron setback and demonstrate progress before the fourth quarter 2026 launch window.